Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elemene injection for refractory malignant pleural effusion
ChiCTR1900028139Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Dec 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Elemene in malignant pleural effusion (MPE), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Objective remission rate. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
Elemene
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on ChiCTR1900028139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028139.